Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Feb 4, 2026 · Quart Barry D sold 15.96K shares at $45.22/share ($721.6K); exercised options for 15.96K shares

Quart Barry D sold 15.96K shares at $45.22/share ($721.6K); exercised options for 15.96K shares

xslF345X05/form4-02042026_110219.xml

xslF345X05/form4-02042026_110219.xmlSEC.gov

Graphics and non-inline formats (not embedded below).